Medicenna Therapeutics Corp. - COM (MDNAF)

CUSIP: 58490H107

Q2 2021 13F Holders as of 30 Jun 2021

Type / Class
Equity / COM
Total 13F shares
4,631,996
Share change
-865,181
Total reported value
$13,969,982
Price per share
$3.01
Number of holders
24
Value change
-$3,500,624
Number of buys
15
Number of sells
12

Quarterly Holders Quick Answers

What is CUSIP 58490H107?
CUSIP 58490H107 identifies MDNAF - Medicenna Therapeutics Corp. - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Medicenna Therapeutics Corp. - COM (MDNAF) as of Q2 2021

As of 30 Jun 2021, Medicenna Therapeutics Corp. - COM (MDNAF) was held by 24 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 4,631,996 shares. The largest 10 holders included AWM Investment Company, Inc., Board of Trustees of The Leland Stanford Junior University, AIGH Capital Management LLC, Verition Fund Management LLC, ACT Capital Management, LLC, Worth Venture Partners, LLC, SILVERARC CAPITAL MANAGEMENT, LLC, TOCQUEVILLE ASSET MANAGEMENT L.P., Maven Securities LTD, and MORGAN STANLEY. This page lists 24 institutional shareholders reporting positions in this security for the Q2 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.